Acasti Pharma Inc. (CVE:ACST – Get Rating) shares reached a new 52-week low on Friday . The company traded as low as C$1.03 and last traded at C$1.04, with a volume of 300 shares traded. The stock had previously closed at C$1.03.
Acasti Pharma Stock Up 1.0 %
The stock has a market capitalization of C$46.39 million and a price-to-earnings ratio of -1.74. The business’s 50-day moving average is C$1.11 and its two-hundred day moving average is C$1.25. The company has a quick ratio of 10.62, a current ratio of 11.13 and a debt-to-equity ratio of 0.78.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.